Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
Clinical trial NCT00832390 · COMPLETED
Trial details
- NCT number
- NCT00832390
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-14
- Primary completion
- 2008-07-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.